Greenwich Lifesciences Inc (GLSI)

Healthcare Pharmaceuticals & Medical Research Pharmaceuticals

Track

Stock chart

Ticker: GLSI Exchange: NAS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Earnings

Value bought

Past 90 days

Value sold

Past 90 days

Net insiders buying

Past 90 days

Trades (buy and sell)

Past 90 days

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2025-04-08	2025-04-07	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	1,000 +0.1% 9.10 USD 32,760	1,000 +0.1%	9.10	USD 100,000
2025-04-07	2025-04-04	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	1,000 +0.1% 8.73 USD 48,015	1,000 +0.1%	8.73	USD 100,000
2025-01-13	2025-01-10	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	2,500 +0.0% 12.51 USD 31,275	2,500 +0.0%	12.51	USD 31,275
2025-01-08	2025-01-07	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	1,800 +0.0% 13.75 USD 24,750	1,800 +0.0%	13.75	USD 24,750
2025-01-08	2025-01-06	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	1,100 +0.0% 13.31 USD 14,641	1,100 +0.0%	13.31	USD 14,641
2025-01-07	2025-01-03	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	3,400 +0.1% 12.95 USD 44,030	3,400 +0.1%	12.95	USD 44,030
2025-01-06	2025-01-02	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	2,000 +0.0% 11.97 USD 23,940	2,000 +0.0%	11.97	USD 23,940
2025-01-03	2024-12-31	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	2,400 +0.0% 11.36 USD 27,264	2,400 +0.0%	11.36	USD 27,264
2025-01-02	2024-12-30	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	3,200 +0.1% 11.12 USD 35,584	3,200 +0.1%	11.12	USD 35,584
2024-11-25	2024-11-21	B Purchase	Thompson Jaye VP Clinical Reg Affairs Officer	1,000 +0.4% 12.91 USD 12,910	1,000 +0.4%	12.91	USD 12,910
2024-09-30	2024-09-26	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	1,500 +0.0% 14.63 USD 21,945	1,500 +0.0%	14.63	USD 21,945
2024-09-16	2024-08-12	B Purchase	Thompson Jaye VP Clinical Reg Affairs Officer	800 +0.3% 13.85 USD 11,080	800 +0.3%	13.85	USD 11,080
2024-08-08	2024-08-06	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	2,000 +0.0% 13.81 USD 27,620	2,000 +0.0%	13.81	USD 27,620
2024-08-07	2024-08-05	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	5,500 +0.1% 13.18 USD 72,490	5,500 +0.1%	13.18	USD 72,490
2024-08-05	2024-08-02	B Purchase	Thompson Jaye VP Clinical Reg Affairs Officer	1,000 +0.4% 15.15 USD 15,150	1,000 +0.4%	15.15	USD 15,150
2024-07-24	2024-07-23	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	1,500 +0.0% 15.89 USD 23,835	1,500 +0.0%	15.89	USD 23,835
2024-07-22	2024-07-18	B Purchase	Thompson Jaye VP Clinical Reg Affairs Officer	1,000 +0.4% 16.00 USD 16,000	1,000 +0.4%	16.00	USD 16,000
2024-06-17	2024-06-13	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	174,825 +3.3% 14.30 USD 2,499,998	174,825 +3.3%	14.30	USD 2,499,998
2024-04-03	2024-04-01	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	3,000 +0.1% 19.08 USD 57,240	3,000 +0.1%	19.08	USD 57,240
2024-03-26	2024-03-22	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	2,500 +0.0% 19.98 USD 49,950	2,500 +0.0%	19.98	USD 49,950
2024-03-22	2024-03-20	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	1,500 +0.0% 17.68 USD 26,520	1,500 +0.0%	17.68	USD 26,520
2024-03-07	2024-03-05	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	30,500 +0.6% 12.49 USD 380,945	30,500 +0.6%	12.49	USD 380,945
2024-03-06	2024-03-04	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	4,100 +0.1% 13.03 USD 53,423	4,100 +0.1%	13.03	USD 53,423
2024-02-21	2024-02-16	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	10,800 +0.2% 11.16 USD 120,528	10,800 +0.2%	11.16	USD 120,528
2024-02-20	2024-02-15	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	12,700 +0.2% 11.07 USD 140,589	12,700 +0.2%	11.07	USD 140,589
2023-11-14	2023-11-10	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	5,000 +0.1% 10.17 USD 50,838	5,000 +0.1%	10.17	USD 50,838
2023-11-07	2023-11-03	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	3,500 +0.1% 9.11 USD 31,885	3,500 +0.1%	9.11	USD 31,885
2023-10-31	2023-10-27	B Purchase	Thompson Jaye VP Clinical Reg Affairs Officer	500 +0.2% 8.57 USD 4,285	500 +0.2%	8.57	USD 4,285
2023-10-30	2023-10-26	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	2,500 +0.0% 7.97 USD 19,925	2,500 +0.0%	7.97	USD 19,925
2023-10-27	2023-10-25	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	2,500 +0.0% 7.91 USD 19,775	2,500 +0.0%	7.91	USD 19,775
2023-10-12	2023-10-10	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	1,000 +0.0% 9.07 USD 9,070	1,000 +0.0%	9.07	USD 9,070
2023-10-05	2023-10-04	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	2,000 +0.0% 8.63 USD 17,260	2,000 +0.0%	8.63	USD 17,260
2023-09-28	2023-09-26	B Purchase	Thompson Jaye VP Clinical Reg Affairs Officer	600 +0.2% 8.71 USD 5,226	600 +0.2%	8.71	USD 5,226
2023-09-21	2023-09-19	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	4,000 +0.1% 8.95 USD 35,800	4,000 +0.1%	8.95	USD 35,800
2023-09-13	2023-09-11	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	1,000 +0.0% 9.48 USD 9,480	1,000 +0.0%	9.48	USD 9,480
2023-08-24	2023-08-22	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	1,000 +0.0% 9.97 USD 9,970	1,000 +0.0%	9.97	USD 9,970
2023-08-08	2023-08-04	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	2,000 +0.0% 10.55 USD 21,100	2,000 +0.0%	10.55	USD 21,100
2023-07-25	2023-07-21	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	1,000 +0.0% 9.20 USD 9,200	1,000 +0.0%	9.20	USD 9,200
2023-07-17	2023-07-13	B Purchase	Thompson Jaye VP Clinical Reg Affairs Officer	250 +0.1% 9.49 USD 2,373	250 +0.1%	9.49	USD 2,373
2023-05-18	2023-05-17	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	1,000 +0.0% 11.69 USD 11,690	1,000 +0.0%	11.69	USD 11,690
2023-05-02	2023-04-28	B Purchase	Thompson Jaye VP Clinical Reg Affairs Officer	250 +0.1% 11.22 USD 2,805	250 +0.1%	11.22	USD 2,805
2023-04-21	2023-04-19	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	7,000 +0.1% 11.10 USD 77,700	7,000 +0.1%	11.10	USD 77,700
2023-04-20	2023-04-18	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	2,000 +0.0% 11.12 USD 22,240	2,000 +0.0%	11.12	USD 22,240
2023-04-12	2023-04-11	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	5,000 +0.1% 12.42 USD 62,100	5,000 +0.1%	12.42	USD 62,100
2023-04-12	2023-04-11	B Purchase	Thompson Jaye VP Clinical Reg Affairs Officer	1,000 +0.4% 11.87 USD 11,870	1,000 +0.4%	11.87	USD 11,870
2023-03-16	2023-03-15	B Purchase	Thompson Jaye VP Clinical Reg Affairs Officer	250 +0.1% 12.71 USD 3,178	250 +0.1%	12.71	USD 3,178
2023-03-13	2023-03-10	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	1,000 +0.0% 12.12 USD 12,120	1,000 +0.0%	12.12	USD 12,120
2023-02-28	2023-02-24	B Purchase	Thompson Jaye VP Clinical Reg Affairs Officer	250 +0.1% 15.40 USD 3,849	250 +0.1%	15.40	USD 3,849
2023-02-22	2023-02-17	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	600 +0.0% 16.53 USD 9,918	600 +0.0%	16.53	USD 9,918
2023-02-14	2023-02-10	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	1,000 +0.0% 18.68 USD 18,680	1,000 +0.0%	18.68	USD 18,680
2023-02-07	2023-02-03	B Purchase	Thompson Jaye VP Clinical Reg Affairs Officer	250 +0.1% 20.84 USD 5,210	250 +0.1%	20.84	USD 5,210
2023-01-31	2023-01-27	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	2,000 +0.1% 19.35 USD 38,700	2,000 +0.1%	19.35	USD 38,700
2023-01-30	2023-01-27	B Purchase	Thompson Jaye VP Clinical Reg Affairs Officer	250 +0.1% 19.20 USD 4,800	250 +0.1%	19.20	USD 4,800
2023-01-24	2023-01-20	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	1,500 +0.1% 17.37 USD 26,055	1,500 +0.1%	17.37	USD 26,055
2023-01-17	2023-01-13	B Purchase	Thompson Jaye VP Clinical Reg Affairs Officer	250 +0.1% 16.50 USD 4,125	250 +0.1%	16.50	USD 4,125
2023-01-10	2023-01-06	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	1,500 +0.1% 15.18 USD 22,770	1,500 +0.1%	15.18	USD 22,770
2023-01-03	2022-12-29	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	4,000 +0.1% 15.19 USD 60,760	4,000 +0.1%	15.19	USD 60,760
2022-12-20	2022-12-16	B Purchase	Thompson Jaye VP Clinical Reg Affairs Officer	250 +0.1% 12.94 USD 3,235	250 +0.1%	12.94	USD 3,235
2022-12-20	2022-12-16	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	1,000 +0.0% 13.01 USD 13,010	1,000 +0.0%	13.01	USD 13,010
2022-12-13	2022-12-09	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	2,000 +0.1% 13.11 USD 26,220	2,000 +0.1%	13.11	USD 26,220
2022-12-06	2022-12-02	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	1,000 +0.0% 13.84 USD 13,840	1,000 +0.0%	13.84	USD 13,840
2022-12-06	2022-12-02	B Purchase	Thompson Jaye VP Clinical Reg Affairs Officer	250 +0.1% 13.98 USD 3,495	250 +0.1%	13.98	USD 3,495
2022-11-04	2022-11-02	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	2,000 +0.1% 8.79 USD 17,580	2,000 +0.1%	8.79	USD 17,580
2022-10-17	2022-10-14	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	3,000 +0.1% 9.75 USD 29,250	3,000 +0.1%	9.75	USD 29,250
2022-10-11	2022-10-07	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	2,000 +0.1% 9.72 USD 19,440	2,000 +0.1%	9.72	USD 19,440
2022-10-04	2022-09-30	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	1,000 +0.0% 9.46 USD 9,460	1,000 +0.0%	9.46	USD 9,460
2022-10-03	2022-09-29	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	1,000 +0.0% 9.23 USD 9,230	1,000 +0.0%	9.23	USD 9,230
2022-06-27	2022-06-24	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	6,465 +0.2% 9.13 USD 59,025	6,465 +0.2%	9.13	USD 59,025
2022-06-27	2022-06-24	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	22,535 +0.8% 9.13 USD 205,745	22,535 +0.8%	9.13	USD 205,745
2022-06-17	2022-06-16	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	8,000 +0.3% 7.13 USD 57,040	8,000 +0.3%	7.13	USD 57,040
2022-06-15	2022-06-14	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	12,000 +0.5% 7.91 USD 94,920	12,000 +0.5%	7.91	USD 94,920
2022-06-13	2022-06-10	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	12,000 +0.5% 8.33 USD 99,960	12,000 +0.5%	8.33	USD 99,960
2022-06-10	2022-06-09	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	4,500 +0.4% 10.90 USD 49,050	4,500 +0.4%	10.90	USD 49,050
2022-06-08	2022-06-07	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	6,000 +0.5% 8.55 USD 51,300	6,000 +0.5%	8.55	USD 51,300
2022-06-06	2022-06-03	B Purchase	Patel Snehal CEO and CFO Executive Director Large shareholder	9,250 +0.8% 8.35 USD 77,238	9,250 +0.8%	8.35	USD 77,238

Greenwich Lifesciences Inc (GLSI)

Track

Stock chart

Earnings

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Transactions

Insider

Sort by